Calcitonin.
Sewell
K L
KL
Division of Rheumatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
D000280:Administration, Inhalation; D000368:Aged; D016723:Bone Remodeling / Q000187:drug effects* / Q000502:physiology; D002116:Calcitonin / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy* / Q000503:physiopathology; D010024:Osteoporosis / Q000188:drug therapy / Q000503:physiopathology; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000209:etiology; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D016103:Spinal Fractures / Q000150:complications; D016896:Treatment Outcome
D002116:Calcitonin